Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MRVI stock hub

Maravai LifeSciences Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MRVIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MRVI

In the news

Latest news · MRVI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-41

P25 -105.6P50 -46.5P75 -3.1

ROIC-17

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MRVI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001823239
Company name	Maravai LifeSciences Holdings, Inc.
Country	United States
Country code	US
Cusip	56600D107
Employees	435
Employees Change	-135%
Employees Change Percent	-23.68
Enterprise value	$1.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-11-20
Isin	US56600D1072
Last refreshed	2026-05-10
Market cap	$1.3B
Market cap category	Small-Cap
Price	$4.85
Price currency	USD
Rev Per Employee	470,643.68x
Sector	Healthcare
Sic	2834
Symbol	MRVI
Website	https://www.maravai.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.35%
EV Sales Forward	6.61x
EV/Sales	6.84x
FCF yield	-4.2%
P/B ratio	3.38x
P/S ratio	6.12x
PS Forward	5.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-43.07%
EBITDA Margin	-18.57%
Gross margin	30.12%
Gross Profit	$61.7M
Gross Profit Growth	-31.63%
Gross Profit Growth Q	336.26%
Gross Profit Growth3 Y	-51.93%
Gross Profit Growth5 Y	-26.4%
Net Income	$-104.6M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-92.22%
Profit Margin	-51.07%
Profit Per Employee	$-240,370
ROA	-6.59
Roa5y	4.97
ROCE	-13.15
ROE	-40.98
Roe5y	19.76
ROIC	-16.98
Roic5y	25.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	128.9%
Cagr3y	-30.53%
Cagr5y	-33.45%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	-15.35x
Revenue Growth Q	40.53x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-34.17x
Revenue Growth5 Y	-11.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.24
Assets	$713.2M
Cash	$165.9M
Current Assets	$251.7M
Current Liabilities	$42.6M
Debt	$315M
Debt Equity	$0.85
Equity	$369.1M
Interest Coverage	-3.4
Liabilities	$344.1M
Long Term Assets	$461.5M
Long Term Liabilities	$301.5M
Net Cash	$-149.1M
Net Cash By Market Cap	$-11.91
Net Debt Equity	$0.4
Tangible Book Value	$-62.8M
Tangible Book Value Per Share	$-0.43
WACC	7.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.91
Inventory Turnover	3.17
Net Working Capital	$58.6M
Quick ratio	4.68
Working Capital	$209.1M
Working Capital Turnover	$0.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.15%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	128.77%
200-day SMA	3.19
3Y total return	-66.48%
50-day SMA	3.39
50-day SMA vs 200-day SMA	50over200
5Y total return	-86.94%
All Time High	63.55
All Time High Change	-92.37%
All Time High Date	2021-08-23
All Time Low	1.67
All Time Low Change	191.29%
All Time Low Date	2025-04-17
ATR	0.25
Beta	0.62
Beta1y	1.78
Beta2y	1.39
Ch YTD	49.23
High	4.95
High52	4.95
High52 Date	2026-05-08
High52ch	-2.02%
Low	4.36
Low52	1.95
Low52 Date	2025-05-16
Low52ch	148.72%
Ma50ch	43.24%
Premarket Change Percent	7.87
Premarket Price	$4.25
Premarket Volume	117,732
Price vs 200-day SMA	52.04%
RSI	81.83
RSI Monthly	45.8
RSI Weekly	69.71
Sharpe ratio	1.42x
Sortino ratio	2.65
Total Return	-3.15%
Tr YTD	49.23
Tr1m	67.82%
Tr1w	30.03%
Tr3m	54.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	53,312,576x
Earnings Revenue Estimate Growth	13.79x
Operating Income	$-88.2M
Operating margin	-43.07
Price target	$4.38
Price Target Change	$-9.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98,562,068%
Float Percent	38.17%
Net Borrowing	-55,440,000
Shares Insiders	4.43%
Shares Institutions	65.89%
Shares Out	258,190,244
Shares Qo Q	0.93%
Shares Yo Y	3.15%
Short Float	9.38%
Short Ratio	4.62
Short Shares	3.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-79.1M
Average Volume	2,469,239.95x
Bv Per Share	1.43
CAPEX	$-13.1M
Ch1m	67.82
Ch1w	30.03
Ch1y	128.8
Ch3m	54.46
Ch3y	-66.48
Ch5y	-86.94
Ch6m	68.99
Change	23.1%
Change From Open	10.48
Close	3.94
Days Gap	11.42
Depreciation Amortization	50,158,000
Dollar Volume	54,536,460.3
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-88.2M
EBITDA	$-38M
EPS	$-0.72
F Score	3
FCF	$-52.6M
FCF EV Yield	-3.75x
FCF Per Share	$-0.2
Financing CF	-66,825,000
Fiscal Year End	December
Founded	2,014
Goodwill	129,429,000
Income Tax	$-4.5M
Investing CF	-12,713,000
Ipr	-82.04
Iprfo	-84.82
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	3.4
Ma150ch	42.56%
Ma20	3.66
Ma20ch	32.66%
Net CF	-119,131,000
Next Earnings Date	2026-08-10
Open	4.39
Optionable	Yes
Position In Range	83.05
Post Close	4.85
Postmarket Change Percent	-2.68
Postmarket Price	$4.72
Ppne	146,930,000
Pre Close	3.94
Price Date	2026-05-08
Relative Volume	4.55x
Revenue	204,730,000x
SBC By Revenue	12.95x
Share Based Comp	26,514,000
Tax By Revenue	-2.21x
Tr6m	68.99%
Us State	California
Volume	11,244,631
Z Score	0.96

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MRVI pay a dividend?

Capital-return profile for this ticker.

Performance

MRVI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MRVI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+65.9%

Float: +38.2% of shares outstanding

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MRVI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

81.8

Above 70: short-term overbought

Price vs 200-day MA

+52.0%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

1.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MRVI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MRVI stock rating?

Maravai LifeSciences Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MRVI analysis?

The full report lives at /stocks/MRVI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MRVI?

The latest report frames MRVI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MRVI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.